Simultaneous Dual Protein Labeling Using a Triorthogonal Reagent
Overview
Authors
Affiliations
Construction of heterofunctional proteins is a rapidly emerging area of biotherapeutics. Combining a protein with other moieties, such as a targeting element, a toxic protein or small molecule, and a fluorophore or polyethylene glycol (PEG) group, can improve the specificity, functionality, potency, and pharmacokinetic profile of a protein. Protein farnesyl transferase (PFTase) is able to site-specifically and quantitatively prenylate proteins containing a C-terminal CaaX-box amino acid sequence with various modified isoprenoids. Here, we describe the design, synthesis, and application of a triorthogonal reagent, 1, that can be used to site-specifically incorporate an alkyne and aldehyde group simultaneously into a protein. To illustrate the capabilities of this approach, a protein was enzymatically modified with compound 1 followed by oxime ligation and click reaction to simultaneously incorporate an azido-tetramethylrhodamine (TAMRA) fluorophore and an aminooxy-PEG moiety. This was performed with both a model protein [green fluorescent protein (GFP)] as well as a therapeutically useful protein [ciliary neurotrophic factor (CNTF)]. Next, a protein was enzymatically modified with compound 1 followed by coupling to an azido-bis-methotrexate dimerizer and aminooxy-TAMRA. Incubation of that construct with a dihydrofolate reductase (DHFR)-DHFR-anti-CD3 fusion protein resulted in the self-assembly of nanoring structures that were endocytosed into T-leukemia cells and visualized therein. These results highlight how complex multifunctional protein assemblies can be prepared using this facile triorthogonal approach.
Wang Y, Kilic O, Rozumalski L, Distefano M, Wagner C Bioconjug Chem. 2024; 35(5):582-592.
PMID: 38701361 PMC: 11633779. DOI: 10.1021/acs.bioconjchem.4c00004.
Bioorthogonal labeling and profiling of N6-isopentenyladenosine (i6A) modified RNA.
Li Y, Zhou H, Chen S, Li Y, Guo Y, Chen X Nucleic Acids Res. 2024; 52(6):2808-2820.
PMID: 38426933 PMC: 11014277. DOI: 10.1093/nar/gkae150.
Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.
Alexander A, Elshahawi S Chembiochem. 2023; 24(17):e202300372.
PMID: 37338668 PMC: 10496146. DOI: 10.1002/cbic.202300372.
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry.
Debon A, Siirola E, Snajdrova R JACS Au. 2023; 3(5):1267-1283.
PMID: 37234110 PMC: 10207132. DOI: 10.1021/jacsau.2c00617.
Site-specific dual encoding and labeling of proteins via genetic code expansion.
Bednar R, Karplus P, Mehl R Cell Chem Biol. 2023; 30(4):343-361.
PMID: 36977415 PMC: 10764108. DOI: 10.1016/j.chembiol.2023.03.004.